Trial Profile
Role of Mosapride in Patients With Gastroesophageal Reflux Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2010
Price :
$35
*
At a glance
- Drugs Mosapride (Primary) ; Lansoprazole
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 01 Aug 2010 Results have been published in the British Journal of Clinical Pharmacology.
- 05 May 2010 Results have been presented at Digestive Disease Week (DDW) 2010.
- 15 May 2009 Actual patient number (114) added as reported by ClinicalTrials.gov.